Xtant Medical Holdings Inc (XTNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 32,357 | 33,255 | 35,411 | 32,904 | 31,514 |
| Cost of Goods | 14,603 | 11,263 | 11,127 | 12,661 | 15,489 |
| Gross Profit | 17,754 | 21,992 | 24,284 | 20,243 | 16,025 |
| Operating Expenses | 19,301 | 19,714 | 19,787 | 19,841 | 18,395 |
| Operating Income | -944 | 2,541 | 4,624 | 1,063 | -1,881 |
| Interest Expense | 718 | 904 | 1,004 | 1,045 | 1,134 |
| Other Income | 3,260 | -72 | 185 | 15 | -128 |
| Pre-tax Income | 1,598 | 1,565 | 3,805 | 33 | -3,143 |
| Income Tax | 1,541 | 257 | 255 | -25 | 21 |
| Net Income Continuous | 57 | 1,308 | 3,550 | 58 | -3,164 |
| Net Income | $57 | $1,308 | $3,550 | $58 | $-3,164 |
| EPS Basic Total Ops | N/A | 0.01 | 0.03 | 0.00 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | 0.01 | 0.03 | 0.00 | -0.02 |
| EPS Diluted Total Ops | N/A | 0.01 | 0.02 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | 0.01 | 0.02 | 0.00 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.01 | 0.02 | 0.00 | -0.02 |
| EBITDA(a) | $875 | $3,702 | $5,793 | $2,137 | $-733 |